PMID- 17509021 OWN - NLM STAT- MEDLINE DCOM- 20070613 LR - 20171116 IS - 1350-1925 (Print) IS - 1350-1925 (Linking) VI - 19 IP - 5 DP - 2007 May TI - Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis. PG - 390-400 AB - Oil of mustard (OM), administered intracolonically, produces severe colitis in mice that is maximized within 3 days. The purpose of this study was to characterize the cytokine response, and to establish expression patterns of enteric neuronal mediators and neuronal receptors affected during active colitis. We measured the changes in the mRNA levels for neuronal receptors and mediators by real-time PCR, and cytokine and chemokine protein levels in the affected tissue. Significant increases in neuronal receptors, such as transient receptor potential A1 (TRPA1), cannabinoid type 1 receptor, neurokinin 1 receptor (NK1R) and delta-opioid receptor; prokineticin-1 receptor; and soluble mediators, such as prodynorphin, proenkephalin1, NK1, prokineticin-1 and secretory leukocyte protease inhibitor, occurred. Significant increases in cytokines, such as interleukin (IL)-1beta, IL-6 and granulocyte macrophage colony stimulating factor (GM-CSF), and in chemokines, such as macrophage chemotactic protein 1 (MCP-1), macrophage inflammatory protein 1 (MIP-1alpha) and Kupffer cell derived chemokine (KC), were detected, with no changes in T-cell-derived cytokines. Furthermore, immunodeficient C57Bl/6 RAG2(-/-) mice exhibited OM colitis of equal severity as seen in wt C57Bl/6 and CD-1 mice. The results demonstrate rapidly increased levels of mRNA for neuronal receptors and soluble mediators associated with pain and inflammation, and increases in cytokines associated with macrophage and neutrophil activation and recruitment. Collectively, the data support a neurogenic component in OM colitis coupled with a myeloid cell-related, T- and B-cell-independent inflammatory component. FAU - Kimball, E S AU - Kimball ES AD - Enterology Research Team, Johnson and Johnson Pharmaceutical Research and Development, Spring House, PA 19477, USA. kimballa@verizon.net FAU - Prouty, S P AU - Prouty SP FAU - Pavlick, K P AU - Pavlick KP FAU - Wallace, N H AU - Wallace NH FAU - Schneider, C R AU - Schneider CR FAU - Hornby, P J AU - Hornby PJ LA - eng PT - Journal Article PL - England TA - Neurogastroenterol Motil JT - Neurogastroenterology and motility JID - 9432572 RN - 0 (Cytokines) RN - 0 (Neuropeptides) RN - 0 (Plant Oils) RN - 0 (TRPA1 Cation Channel) RN - 0 (TRPV Cation Channels) RN - 0 (TRPV1 protein, mouse) RN - 0 (Transient Receptor Potential Channels) RN - 0 (Trpa1 protein, mouse) RN - TYY1MA9BSY (mustard oil) SB - IM MH - Animals MH - Colitis/*chemically induced/pathology MH - Colon/metabolism/pathology MH - Cytokines/genetics/*metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout/genetics/metabolism MH - Mustard Plant/*toxicity MH - Neuropeptides/genetics/*metabolism MH - Plant Oils/administration & dosage/*toxicity MH - Sensory Receptor Cells/*metabolism MH - TRPA1 Cation Channel MH - TRPV Cation Channels/genetics/metabolism MH - Transient Receptor Potential Channels/genetics/metabolism EDAT- 2007/05/19 09:00 MHDA- 2007/06/15 09:00 CRDT- 2007/05/19 09:00 PHST- 2007/05/19 09:00 [pubmed] PHST- 2007/06/15 09:00 [medline] PHST- 2007/05/19 09:00 [entrez] AID - NMO939 [pii] AID - 10.1111/j.1365-2982.2007.00939.x [doi] PST - ppublish SO - Neurogastroenterol Motil. 2007 May;19(5):390-400. doi: 10.1111/j.1365-2982.2007.00939.x.